Rapid Micro Biosystems, Inc. (RPID) Reports In-Line Q3 EPS ; Offers Guidance

Rapid Micro Biosystems, Inc. (NASDAQ: RPID) reported Q3 EPS of ($0.31), in-line with the analyst estimate of ($0.31). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $5.55 million.

GUIDANCE:

Rapid Micro Biosystems, Inc. sees FY2023 revenue of ~$22 million, versus the consensus of $22.26 million.

For earnings history and earnings-related data on Rapid Micro Biosystems, Inc. (RPID) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• John Wiley & Sons, Inc. (WLY) Tops Q4 EPS by 12c; offers outlook
• John Wiley & Sons, Inc. (WLYB) Tops Q4 EPS by 12c; Offers Outlook